Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT

Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study

(2021) Akshay Sharma et al.   Lancet Haematology

Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2

(2021) Joseph E. Ebinger et al.   NATURE MEDICINE

Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series

(2021) William A. Werbel et al.   ANNALS OF INTERNAL MEDICINE

Antibody response after second BNT162b2 dose in allogeneic HSCT recipients

(2021) Rabah Redjoul et al.   LANCET

COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey

(2021) Per Ljungman et al.   LEUKEMIA

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients

(2021) Nassim Kamar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study

(2021) Kazimieras Maneikis et al.   Lancet Haematology

Antipneumococcal Seroprotection Years After Vaccination in Allogeneic Hematopoietic Cell Transplant Recipients

(2019) Christine Robin et al.   CLINICAL INFECTIOUS DISEASES